Arrowhead Pharmaceuticals, Inc. is a company in the U.S. stock market and it is a holding in 79 U.S.-traded ETFs. ARWR has around 14.6M shares in the U.S. ETF market. The largest ETF holder of ARWR is the iShares Core S&P Mid-Cap ETF (IJH), with approximately 2.71M shares. Investors may also find of interest that the ETF with the largest allocation to ARWR stock is Global X Genomics & Biotechnology ETF (GNOM), with a portfolio weight of 3.96%. On average, U.S. ETFs allocate 0.38% of ARWR to their portfolios.
Additionally, ARWR is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with ARWR as a holding is the ProShares Ultra NASDAQ Biotechnology (BIB), with a return of 50.24%.